Cargando…
The HYPERFlax trial for determining the anti-HYPERtensive effects of dietary flaxseed in newly diagnosed stage 1 hypertensive patients: study protocol for a randomized, double-blinded, controlled clinical trial
BACKGROUND: In 2013 the World Health Organization deemed hypertension as a global crisis as it is the leading risk factor attributed to global mortality. Therefore, there is a great need for effective alternative treatment strategies to combat a condition that affects 40% of adults worldwide. Recent...
Autores principales: | Caligiuri, Stephanie PB, Penner, Brian, Pierce, Grant N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073186/ https://www.ncbi.nlm.nih.gov/pubmed/24938224 http://dx.doi.org/10.1186/1745-6215-15-232 |
Ejemplares similares
-
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019) -
The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial
por: Movahed, Ali, et al.
Publicado: (2016) -
Dietary Flaxseed as a Strategy for Improving Human Health
por: Parikh, Mihir, et al.
Publicado: (2019) -
Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial
por: Shi, Haoyue, et al.
Publicado: (2020) -
A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial
por: Fuchs, Flávio D, et al.
Publicado: (2011)